{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:48:42Z","timestamp":1787626122528,"version":"build-2736575974"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY210"],"award-info":[{"award-number":["2023KY210"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bcp.2025.117618","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T15:12:14Z","timestamp":1765120334000},"page":"117618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Advances in TCDD-inducible poly(ADP-ribose) polymerase (TiPARP\/PARP7) research: From molecular mechanisms to therapeutic applications"],"prefix":"10.1016","volume":"244","author":[{"given":"Chen-Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Dong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Qun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lirussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-0930","authenticated-orcid":false,"given":"Xiang-Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117618_b0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1101\/gad.334425.119","article-title":"The impact of PARPs and ADP-ribosylation on inflammation and host\u2013pathogen interactions","volume":"34","author":"Fehr","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.molcel.2023.04.009","article-title":"PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools","volume":"83","author":"Dasovich","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tibs.2024.12.013","article-title":"PARPs and ADP-ribosylation-mediated biomolecular condensates: determinants, dynamics, and disease implications","volume":"50","author":"Liu","year":"2025","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2025.117618_b0020","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.cell.2023.08.030","article-title":"ADP-ribosylation from molecular mechanisms to therapeutic implications","volume":"186","author":"Suskiewicz","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.molcel.2015.06.001","article-title":"SnapShot: ADP-Ribosylation Signaling","volume":"58","author":"Hottiger","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0030","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.molcel.2015.06.006","article-title":"PARPs and ADP-Ribosylation: Fifty Years\u2026 and counting","volume":"58","author":"Kraus","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0035","first-page":"S289","article-title":"The Concise Guide to PHARMACOLOGY 2023\/24: Enzymes","volume":"180","author":"Alexander","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117618_b0040","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1111\/febs.16142","article-title":"ADP-ribosyltransferases, an update on function and nomenclature","volume":"289","author":"L\u00fcscher","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2025.117618_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102347","article-title":"ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases","volume":"98","author":"Hao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2025.117618_b0065","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1093\/nar\/gkab136","article-title":"ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function","volume":"49","author":"Weixler","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117618_b0070","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41467-019-08859-x","article-title":"Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation","volume":"10","author":"O\u2019Sullivan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0075","article-title":"Functional roles of ADP-ribosylation writers, readers and erasers","volume":"10","author":"Li","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0080","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibs.2024.08.006","article-title":"The quest to identify ADP-ribosylation readers: methodological advances","volume":"49","author":"Weijers","year":"2024","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2025.117618_b0085","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.molcel.2022.02.021","article-title":"The Expanding Universe of PARP1-Mediated Molecular and Therapeutic Mechanisms","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/nar\/gkv1383","article-title":"Readers of poly(ADP-ribose): designed to be fit for purpose","volume":"44","author":"Teloni","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117618_b0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1101\/gad.334284.119","article-title":"The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism","volume":"34","author":"Sz\u00e1nt\u00f3","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1101\/gad.334433.119","article-title":"PARPs and ADP-ribosylation in RNA biology: From RNA expression and processing to protein translation and proteostasis","volume":"34","author":"Kim","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.2001.5987","article-title":"TCDD-inducible poly(ADP-ribose) polymerase: A novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"289","author":"Ma","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0003-9861(02)00339-9","volume":"404","author":"Ma","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2025.117618_b0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/nar\/gks1337","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation","volume":"41","author":"MacPherson","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117618_b0120","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.bbrc.2017.12.113","article-title":"The aryl hydrocarbon receptor regulates the expression of TIPARP and its cis long non-coding RNA, TIPARP-AS1","volume":"495","author":"Grimaldi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cotox.2017.01.013","article-title":"AHR toxicity and signaling: Role of TIPARP and ADP-ribosylation","volume":"2","author":"Matthews","year":"2017","journal-title":"Curr. Opin Toxicol."},{"key":"10.1016\/j.bcp.2025.117618_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.128084","article-title":"The aryl hydrocarbon receptor: A predominant mediator for the toxicity of emerging dioxin-like compounds","volume":"426","author":"Zhang","year":"2022","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.bcp.2025.117618_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s44321-025-00214-6","article-title":"PARP7 as a new target for activating anti-tumor immunity in cancer","author":"Popova","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2025.117618_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400087","article-title":"Unleashing viral mimicry: a combinatorial strategy to enhance the efficacy of PARP7 inhibitors","volume":"47","author":"Manetsch","year":"2025","journal-title":"Bioessays"},{"key":"10.1016\/j.bcp.2025.117618_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04346-0","article-title":"TIPARP is involved in the regulation of intraocular pressure","volume":"5","author":"Zhang","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0150","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241184","article-title":"PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease","volume":"222","author":"Jeltema","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2025.117618_b0155","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1042\/BCJ20180347","article-title":"Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP\/ARTD14) catalytic activity","volume":"475","author":"Gomez","year":"2018","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2025.117618_b0160","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1038\/ncomms5426","article-title":"Family-wide analysis of poly(ADP-ribose) polymerase activity","volume":"5","author":"Vyas","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0165","first-page":"226","article-title":"Mono-ADP-ribosylation, a MARylationmultifaced modification of protein","volume":"10","author":"Wu","year":"2024","journal-title":"DNA and RNA: Characterizations, Functions and Mechanisms, Cell Death Discov"},{"key":"10.1016\/j.bcp.2025.117618_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004403","article-title":"Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts","volume":"10","author":"Daugherty","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bcp.2025.117618_b0175","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s44318-025-00391-7","article-title":"Ubiquitin is directly linked via an ester to protein-conjugated mono-ADP-ribose","volume":"44","author":"Bejan","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117618_b0180","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1038\/s41467-021-24723-3","article-title":"Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal","volume":"12","author":"Rack","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60480","article-title":"Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets","volume":"10","author":"Rodriguez","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117618_b0205","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.celrep.2018.07.083","article-title":"Systems-wide analysis of serine ADP-Ribosylation reveals widespread occurrence and site-specific overlap with phosphorylation","volume":"24","author":"Larsen","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117618_b0290","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1042\/BCJ20210378","article-title":"PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus","volume":"478","author":"Kamata","year":"2021","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2025.117618_b0250","series-title":"Proceedings of the National Academy of Sciences 117","first-page":"13447","article-title":"TiPARP forms nuclear condensates to degrade HIF-1\u03b1 and suppress tumorigenesis","author":"Zhang","year":"2020"},{"key":"10.1016\/j.bcp.2025.117618_b0295","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1074\/jbc.M115.660100","article-title":"Loss of the mono-ADP-ribosyltransferase, Tiparp, increases sensitivity to dioxin-induced steatohepatitis and lethality","volume":"290","author":"Ahmed","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/toxsci\/kfab075","article-title":"2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-inducible poly-ADP-ribose polymerase (TIPARP\/PARP7) catalytic mutant mice (TiparpH532A) exhibit increased sensitivity to TCDD-induced hepatotoxicity and lethality","volume":"183","author":"Hutin","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117618_b0190","doi-asserted-by":"crossref","unstructured":"Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation, (n.d.). https:\/\/doi.org\/10.1126\/science.aaf7865.","DOI":"10.1126\/science.aaf7865"},{"key":"10.1016\/j.bcp.2025.117618_b0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4939-6993-7_9","article-title":"Identification of protein substrates of specific PARP enzymes using analog-sensitive PARP mutants and a \u2018Clickable\u2019 NAD+ Analog","volume":"1608","author":"Gibson","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60481","article-title":"Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells","volume":"10","author":"Palavalli Parsons","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117618_b0210","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41467-021-23055-6","article-title":"Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0215","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/MCB.01658-12","article-title":"Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3","volume":"33","author":"He","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0220","doi-asserted-by":"crossref","first-page":"21514","DOI":"10.1074\/jbc.M113.458067","article-title":"Aryl hydrocarbon receptor activation by dioxin targets phosphoenolpyruvate carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly(ADP-ribose) polymerase (TiPARP)","volume":"288","author":"Diani-Moore","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0225","doi-asserted-by":"crossref","first-page":"38801","DOI":"10.1074\/jbc.M110.131573","article-title":"Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect","volume":"285","author":"Diani-Moore","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0968-0004(01)01787-X","article-title":"The WWE domain: a common interaction module in protein ubiquitination and ADP ribosylation","volume":"26","author":"Aravind","year":"2001","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2025.117618_b0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.182618.111","article-title":"Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination","volume":"26","author":"Wang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature13826","article-title":"Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal","volume":"517","author":"DaRosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117618_b0245","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.febslet.2012.09.009","article-title":"Structural insight into the interaction of ADP-ribose with the PARP WWE domains","volume":"586","author":"He","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2025.117618_b0255","unstructured":"J.R.A. Kuttiyatveetil, Crystal structures and functional analysis of the ZnF5-WWE1-WWE2 region of PARP13\/ZAP define a distinctive mode of engaging poly(ADP-ribose), OPEN ACCESS (n.d.)."},{"key":"10.1016\/j.bcp.2025.117618_b0260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nri.2016.129","article-title":"RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins","volume":"17","author":"Fu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0265","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaa059","article-title":"Zinc finger proteins in the host-virus interplay: multifaceted functions based on their nucleic acid-binding property","volume":"45","author":"Wang","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bcp.2025.117618_b0270","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/JVI.03443-13","article-title":"Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication","volume":"88","author":"Atasheva","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117618_b0275","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1621508114","article-title":"Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response","volume":"114","author":"Kozaki","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117618_b0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni.3422","article-title":"Constitutive aryl hydrocarbon receptor signaling constrains type I interferon\u2013mediated antiviral innate defense","volume":"17","author":"Yamada","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0285","doi-asserted-by":"crossref","unstructured":"H. Jiao, Z. Yan, X. Zhai, Y. Yang, N. Wang, X. Li, Z. Jiang, S. Su, Transcriptome screening identifies TIPARP as an antiviral host factor against the Getah virus, J Virol 97 (n.d.) e00591-23. https:\/\/doi.org\/10.1128\/jvi.00591-23.","DOI":"10.1128\/jvi.00591-23"},{"key":"10.1016\/j.bcp.2025.117618_b0300","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1042\/BJ20151077","article-title":"TCDD-inducible poly-ADP-ribose polymerase (TIPARP\/PARP7) mono-ADP-ribosylates and co-activates liver X receptors","volume":"473","author":"Bindesb\u00f8ll","year":"2016","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2025.117618_b0305","doi-asserted-by":"crossref","first-page":"21723","DOI":"10.1038\/s41598-023-49100-6","article-title":"Identification and partial characterization of new cell density-dependent nucleocytoplasmic shuttling proteins and open chromatin","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117618_b0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309047120","article-title":"PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis","volume":"120","author":"Manetsch","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2025.117618_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101117","article-title":"PARPs in lipid metabolism and related diseases","volume":"84","author":"Sz\u00e1nt\u00f3","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bcp.2025.117618_b0330","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/ijms20092312","article-title":"3-Methylcholanthrene induces chylous ascites in TCDD-inducible poly-ADP-ribose polymerase (Tiparp) knockout mice","volume":"20","author":"Cho","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.bcp.2025.117618_b0335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrm3601","article-title":"Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation","volume":"14","author":"Feijs","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0340","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2478\/jtim-2021-0032","article-title":"TCDD-inducible Poly (ADP-ribose) polymerase promotes adipogenesis of both brown and white preadipocytes","volume":"10","author":"Liu","year":"2022","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.bcp.2025.117618_b0345","doi-asserted-by":"crossref","unstructured":"G. Grimaldi, B. Vagaska, O. Ievglevskyi, E. Kondratskaya, J.C. Glover, J. Matthews, Loss of Tiparp Results in Aberrant Layering of the Cerebral Cortex, eNeuro 6 (2019) ENEURO.0239-19.2019. https:\/\/doi.org\/10.1523\/ENEURO.0239-19.2019.","DOI":"10.1523\/ENEURO.0239-19.2019"},{"key":"10.1016\/j.bcp.2025.117618_b0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-014-0093-y","article-title":"Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases","volume":"2","author":"Li","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0355","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/brain\/awu350","article-title":"Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering","volume":"138","author":"Dachet","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117618_b0360","article-title":"A preliminary study of effect of melatonin on inflammation and hypoxia-related factors in a mouse model of elastase-induced intracranial aneurysm","volume":"15","author":"Naren","year":"2025","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.bcp.2025.117618_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107508","article-title":"New TIPARP inhibitor rescues mitochondrial function and brain injury in ischemic stroke","volume":"210","author":"Cai","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117618_b0370","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1523\/JNEUROSCI.0299-19.2019","article-title":"Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p\/TIPARP","volume":"39","author":"Wu","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117618_b0375","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15548627.2018.1458173","article-title":"Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke","volume":"14","author":"Han","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2025.117618_b0380","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/ijms23020920","article-title":"Reduced colonic mucosal injury in 2,3,7,8-tetrachlorodibenzo-p-dioxin Poly ADP-ribose polymerase (TIPARP\/PARP7)-deficient mice","volume":"23","author":"Hutin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117618_b0385","article-title":"Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration","volume":"15","author":"Kannen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0390","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1158\/1535-7163.MCT-21-0841","article-title":"A Whole-Genome CRISPR Screen Identifies AHR loss as a Mechanism of Resistance to a PARP7 Inhibitor","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2025.117618_b0395","article-title":"PARP7 inhibitors and AHR agonists act synergistically across a wide range of cancer models","author":"Chen","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2025.117618_b0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2019.05.007","article-title":"Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation","volume":"167","author":"Lu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117618_b0505","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ccell.2021.06.018","article-title":"PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity","volume":"39","author":"Gozgit","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117618_b0510","doi-asserted-by":"crossref","unstructured":"R. M, T. S, S. Vs, H. D, O. Ne, M. A, A. Jh, G. Dm, M. J, PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor \u03b1 Signaling in Human Breast Cancer Cells, Cells 10 (2021). https:\/\/doi.org\/10.3390\/cells10030623.","DOI":"10.3390\/cells10030623"},{"key":"10.1016\/j.bcp.2025.117618_b0515","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers15143689","article-title":"Loss of PARP7 increases Type I interferon signaling in EO771 breast cancer cells and prevents mammary tumor growth by increasing antitumor immunity","volume":"15","author":"Rasmussen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117618_b0520","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm6812","article-title":"Zinc-finger PARP proteins ADP-ribosylate alphaviral proteins and are required for interferon-\u03b3-mediated antiviral immunity","volume":"11","author":"Ryan","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2025.117618_b0405","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-1-0716-2891-1_24","article-title":"Quantification of PARP7 protein levels and PARP7 inhibitor target engagement in cells using a split nanoluciferase system","volume":"2609","author":"Duell","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0410","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1021\/acs.jmedchem.2c01460","article-title":"[1,2,4]Triazolo[3,4-b]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes","volume":"66","author":"Murthy","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0415","doi-asserted-by":"crossref","unstructured":"K.W. Bock, From TCDD-mediated toxicity to searches of physiologic AHR functions, (2018).","DOI":"10.1016\/j.bcp.2018.07.032"},{"key":"10.1016\/j.bcp.2025.117618_b0420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-2797(02)00070-4","article-title":"Aryl hydrocarbon receptors: diversity and evolution1","volume":"141","author":"Hahn","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2025.117618_b0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcp.2019.06.015","article-title":"Aryl hydrocarbon receptor (AHR): From selected human target genes and crosstalk with transcription factors to multiple AHR functions","volume":"168","author":"Bock","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117618_b0430","first-page":"347","article-title":"Hepatocyte-specific deletion of TIPARP, a negative regulator of the aryl hydrocarbon receptor","volume":"165","author":"Hutin","year":"2018","journal-title":"Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome, Toxicological Sciences"},{"key":"10.1016\/j.bcp.2025.117618_b0435","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.3390\/ijms15057939","article-title":"Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling","volume":"15","author":"MacPherson","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117618_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100886","article-title":"Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR","volume":"297","author":"Rijo","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0445","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acs.jmedchem.2c01452","article-title":"Discovery of the potent and highly selective PARP7 inhibitor as a novel immunotherapeutic agent for tumors","volume":"66","author":"Gu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0450","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1101\/gad.1564207","article-title":"Cell- and gene-specific regulation of primary target genes by the androgen receptor","volume":"21","author":"Bolton","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0455","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-018-4848-x","article-title":"Genomic analysis of DNA repair genes and androgen signaling in prostate cancer","volume":"18","author":"Jividen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2025.117618_b0315","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/cells10020363","article-title":"Post-transcriptional regulation of PARP7 protein stability is controlled by androgen signaling","volume":"10","author":"Kamata","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117618_b0460","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acschembio.3c00305","article-title":"Synthetic dual cysteine-ADP Ribosylated peptides from the androgen receptor are recognized by the DTX3L\/PARP9 complex","volume":"18","author":"Wijngaarden","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0465","first-page":"1","article-title":"Parp7 generates an ADP-ribosyl degron that controls negative feedback of androgen signaling","author":"Wierbi\u0142owicz","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117618_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166912","article-title":"Simplicity is the Ultimate Sophistication\u2014Crosstalk of Post-translational modifications on the RNA Polymerase II","volume":"433","author":"Venkat Ramani","year":"2021","journal-title":"J. Molecular Biology"},{"key":"10.1016\/j.bcp.2025.117618_b0475","article-title":"Anticancer or carcinogenic?","volume":"242","author":"Shen","year":"2023","journal-title":"The Role of Estrogen Receptor \u03b2 in Breast Cancer Progression, Pharmacology & Therapeutics"},{"key":"10.1016\/j.bcp.2025.117618_b0480","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1158\/1078-0432.CCR-21-2600","article-title":"FDA Drug approvals for breast cancer: A decade in review","volume":"28","author":"Arora","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117618_b0485","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/cells10030623","article-title":"PARP7 and Mono-ADP-ribosylation negatively regulate estrogen receptor \u03b1 signaling in human breast cancer cells","volume":"10","author":"Rasmussen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117618_b0490","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1128\/MCB.25.13.5317-5328.2005","article-title":"Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters","volume":"25","author":"Matthews","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0495","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/toxsci\/kfp144","article-title":"Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters","volume":"111","author":"Ahmed","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117618_b0500","doi-asserted-by":"crossref","unstructured":"P. Manetsch, M.O. Hottiger, Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors, BioEssays n\/a (n.d.) 2400087. https:\/\/doi.org\/10.1002\/bies.202400087.","DOI":"10.1002\/bies.202400087"},{"key":"10.1016\/j.bcp.2025.117618_b0565","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12935-023-02870-5","article-title":"Chorioallantoic membrane assay revealed the role of TIPARP (2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly (ADP-ribose) polymerase) in lung adenocarcinoma-induced angiogenesis","volume":"23","author":"Miura","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2025.117618_b0570","first-page":"8991","article-title":"TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP)","volume":"11","author":"Cheng","year":"2019","journal-title":"A Novel Therapeutic Target of Breast Cancer, Cancer Manag Res"},{"key":"10.1016\/j.bcp.2025.117618_b0575","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1101\/gad.334425.119","article-title":"The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions","volume":"34","author":"Fehr","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.117618_b0580","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01743-19","article-title":"Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression","volume":"94","author":"Grunewald","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117618_b0585","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70013","article-title":"PARP7i Clinical Candidate RBN-2397 Exerts Antiviral activity by Modulating Interferon-\u03b2 Associated Innate Immune Response in Macrophages","volume":"85","author":"Du","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bcp.2025.117618_b0590","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chembiol.2022.11.012","article-title":"Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-\u03b2 signaling","volume":"30","author":"Sanderson","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107469","article-title":"Discovery of highly potent PARP7 inhibitors for cancer immunotherapy","volume":"148","author":"Yang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0560","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1021\/acs.jmedchem.4c00296","article-title":"Novel bifunctional conjugates targeting PD-L1\/PARP7 as dual immunotherapy for potential cancer treatment","volume":"67","author":"Gao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0525","article-title":"Discovery of highly selective PARP7 inhibitors with a novel scaffold for cancer immunotherapy","author":"Gu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0600","doi-asserted-by":"crossref","unstructured":"Interferon-Stimulated Poly(ADP-Ribose) Polymerases Are Potent Inhibitors of Cellular Translation and Virus Replication, (n.d.). https:\/\/doi.org\/10.1128\/jvi.03443-13.","DOI":"10.1128\/JVI.03443-13"},{"key":"10.1016\/j.bcp.2025.117618_b0605","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1128\/JVI.00733-12","article-title":"New PARP gene with an anti-alphavirus function","volume":"86","author":"Atasheva","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2025.117618_b0610","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.1074\/jbc.RA120.015138","article-title":"Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity","volume":"295","author":"Heer","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0615","doi-asserted-by":"crossref","unstructured":"A.P. Ryan, S.E. Delgado-Rodriguez, M.D. Daugherty, Zinc-finger PARP proteins ADP-ribosylate alphaviral proteins and are required for interferon-\u03b3\u2013mediated antiviral immunity, Sci Adv 11 (n.d.) eadm6812. https:\/\/doi.org\/10.1126\/sciadv.adm6812.","DOI":"10.1126\/sciadv.adm6812"},{"key":"10.1016\/j.bcp.2025.117618_b0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007756","article-title":"The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression","volume":"15","author":"Grunewald","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2025.117618_b0625","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41590-019-0527-6","article-title":"RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions","volume":"20","author":"Schwerk","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009202","article-title":"Poly(ADP-ribose) potentiates ZAP antiviral activity","volume":"18","author":"Xue","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2025.117618_b0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ni.1963","article-title":"ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses","volume":"12","author":"Hayakawa","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0640","doi-asserted-by":"crossref","unstructured":"C.D. Heer, D.J. Sanderson, L.S. Voth, Y.M.O. Alhammad, M.S. Schmidt, S.A.J. Trammell, S. Perlman, M.S. Cohen, A.R. Fehr, C. Brenner, Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity, (2020) 2020.04.17.047480. https:\/\/doi.org\/10.1101\/2020.04.17.047480.","DOI":"10.1101\/2020.04.17.047480"},{"key":"10.1016\/j.bcp.2025.117618_b0645","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0650","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fimmu.2020.01510","article-title":"The AHR signaling attenuates autoimmune responses during the development of type 1 diabetes","volume":"11","author":"Yue","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117618_b0655","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00204-021-03134-9","article-title":"Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD+-dependent metabolic adaptation","volume":"95","author":"Bock","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2025.117618_b0660","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/toxsci\/kfab075","article-title":"2,3,7,8-Tetrachlorodibenzo- p -Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP\/PARP7) Catalytic Mutant mice (TiparpH532A) exhibit increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality","volume":"183","author":"Hutin","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117618_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102402","article-title":"Immunomodulatory roles of PARPs: Shaping the tumor microenvironment, one ADP-ribose at a time","volume":"77","author":"Brooks","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101530","article-title":"The aryl hydrocarbon receptor as a target of environmental stressors \u2013 Implications for pollution mediated stress and inflammatory responses","volume":"34","author":"Vogel","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0675","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1021\/acs.jmedchem.2c00281","article-title":"Medicinal chemistry perspective on targeting mono-ADP-ribosylating PARPs with small molecules","volume":"65","author":"Nizi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0680","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/2767-9764.CRC-23-0086","article-title":"Induction of PARP7 creates a vulnerability for growth inhibition by RBN2397 in prostate cancer cells","volume":"3","author":"Yang","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bcp.2025.117618_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116160","article-title":"Discovery of tricyclic PARP7 inhibitors with high potency, selectivity, and oral bioavailability","volume":"266","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0530","first-page":"43","article-title":"Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-\u03b2 signaling, Cell","volume":"30","author":"Sanderson","year":"2023","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117618_b0540","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216235","article-title":"Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance","volume":"15","author":"Wang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2025.117618_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115836","article-title":"Exploring the structural-activity relationship of hexahydropyrazino[1,2-d]pyrido[3,2-b][1,4]oxazine derivatives as potent and orally-bioavailable PARP7 inhibitors","volume":"261","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0550","doi-asserted-by":"crossref","first-page":"14095","DOI":"10.1021\/acs.jmedchem.3c01152","article-title":"Discovery of Quinazoline-2,4(1H,3H)-dione derivatives containing a piperizinone moiety as potent PARP-1\/2 inhibitors\u2500design, synthesis, in vivo antitumor activity, and X-ray crystal structure analysis","volume":"66","author":"Zhou","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0555","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/acs.jmedchem.4c00090","article-title":"Design, Synthesis, and Structure\u2013Activity Relationship of Novel Pyridazinone-based PARP7\/HDACs dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition","volume":"67","author":"Duan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117618_b0685","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.2021.39.15_suppl.3000","article-title":"A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors","volume":"39","author":"Falchook","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.bcp.2025.117618_b0690","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1158\/1538-7445.AM2024-4535","article-title":"Abstract 4535: JAB-26766: a small-molecule, orally bioavailable PARP7 inhibitor with high potency and selectivity","volume":"84","author":"Kang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117618_b0695","article-title":"BY101921: Restoring interferon signaling and anti-tumor immunity through PARP7 inhibition","author":"Sun","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117618_b0700","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1158\/1538-7445.AM2024-7588","article-title":"Abstract 7588: Discovery of NSP-5033: a novel and potent PARP7\/12 dual inhibitor","volume":"84","author":"Chen","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117618_b0705","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12935-024-03223-6","article-title":"TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma","volume":"24","author":"Zhang","year":"2024","journal-title":"Cancer Cell Int."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:28:56Z","timestamp":1766395736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":141,"alternative-id":["S0006295225008834"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117618","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in TCDD-inducible poly(ADP-ribose) polymerase (TiPARP\/PARP7) research: From molecular mechanisms to therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117618"}}